Key result
Implantation of a permanent artificial left ventricle in a 64-year-old terminally ill patient was followed by death five days later due to multiple organ failure.
Case Report (n=1)
No
This news report describes the first human implantation of the HeartMate II permanent artificial left ventricle in a terminally ill patient who survived for 5 days.
Answers are grounded in this paper and cite their sources.
Does not support permanent artificial LV use in terminal illness; leaves open device feasibility for future research.
Surgeons who implanted the first permanent artificial left ventricle in a patient are confident that the tiny device will eventually be used in most heart transplantations around the world. The 64 year old patient was terminally ill when he received the implant, having experienced severe heart problems for several months, and he died five days later on 1 August of multiple organ failure. His own heart had been working at only 10% capacity at the time of the implant. Dr Jacob Lavee, head of the department of cardiothoracic surgery at the Sheba Hospital, near Tel Aviv, performed …
No takes yet. Share an insight, caveat, or question.
Judy Siegel-Itzkovich (2000) conducted a case report in Severe heart failure (n=1). Permanent artificial left ventricle was evaluated on Survival. Implantation of a permanent artificial left ventricle in a 64-year-old terminally ill patient was followed by death five days later due to multiple organ failure.
Synapse has enriched 10 related papers. Consider them for comparative context: